Global Circular RNA Synthesis Service Supply, Demand and Key Producers, 2026-2032
The global Circular RNA Synthesis Service market size is expected to reach $ 234 million by 2032, rising at a market growth of 25.2% CAGR during the forecast period (2026-2032).
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
This report studies the global Circular RNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circular RNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circular RNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circular RNA Synthesis Service total market, 2021-2032, (USD Million)
Global Circular RNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Circular RNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global Circular RNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Circular RNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Circular RNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Circular RNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript Biotech Corporation, VectorBuilder, Guangzhou Geneseed Biotech, uBriGene Biosciences, Yaohai Bio-Pharma, Creative Biogene, Creative Biolabs, BOC Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Circular RNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Circular RNA Synthesis Service Market, By Region:
1. How big is the global Circular RNA Synthesis Service market?
2. What is the demand of the global Circular RNA Synthesis Service market?
3. What is the year over year growth of the global Circular RNA Synthesis Service market?
4. What is the total value of the global Circular RNA Synthesis Service market?
5. Who are the Major Players in the global Circular RNA Synthesis Service market?
6. What are the growth factors driving the market demand?
Circular RNA synthesis services provide integrated technical support for the design, production, purification, and quality control of customized circular RNA molecules based on customer-defined or jointly optimized target sequences. The typical service workflow includes circular RNA sequence design, DNA template construction, in vitro transcription, RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circular RNA samples, preclinical drug substance, process-development packages, and GMP clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials, while downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutions, and hospital research centers. The overall industry gross margin typically around 40%?60%.
The circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although demand is shifting from basic sample preparation toward sequence optimization, circularization process development, impurity control, analytical method establishment, and clinical manufacturing. The early market was primarily served by life-science tools and gene-synthesis companies supplying microgram- to milligram-scale customized samples. As circular RNA drugs, vaccines, and in vivo cell therapy programs advance, several integrated RNA service providers are developing gram-scale production, lipid nanoparticle formulation, and GMP-compliant manufacturing capabilities. Global supply is currently concentrated in China and the United States. Chinese providers have established broad capabilities in research services, sequence analysis, circularization process development, and integrated CRDMO support, while U.S.-based providers generally benefit from broader international customer coverage and established nucleic acid manufacturing infrastructure.
Future competition will shift from demonstrating basic circularization capability toward reliably delivering high-purity, translatable, low-immunogenicity products that meet regulatory requirements. Competitive differentiation will increasingly depend on scarless circularization, long-sequence compatibility, process robustness across different payloads, removal of double-stranded RNA and linear precursors, batch reproducibility, and biological potency testing. Research-grade projects will continue to account for a large number of orders, but most value growth is expected to come from preclinical process development, GMP manufacturing, analytical validation, and LNP formulation. Suppliers with integrated capabilities covering sequence design, template preparation, circularization, purification, analytics, and formulation will be better positioned to retain projects as they progress toward clinical development.
Market growth is being driven by the expanding development of circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo CAR-T, and other gene and cell therapy applications. Compared with building an internal small-scale production platform, outsourcing to specialized providers gives developers access to validated circularization elements, process expertise, analytical methods, and scale-up equipment, helping reduce development risk and shorten timelines to animal studies and regulatory submissions. As projects move from discovery into preclinical and clinical stages, additional testing for purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency increases the value of individual service contracts. Continued interest from large pharmaceutical companies in next-generation RNA technologies may also support greater demand for platform collaboration and outsourced manufacturing.
The main barriers are the lack of harmonized technical standards and differences in how suppliers measure circularization rate, purity, integrity, and expression activity, which make direct service comparison difficult. Conventional PIE methods may introduce residual sequences, sequence restrictions, and unwanted by-products, while ligase-based methods face challenges related to enzyme cost, terminal design, and scale-up. Circularization efficiency, purification recovery, and batch consistency for long RNA sequences still require improvement. Clinical-grade production also requires more stringent raw-material controls, validated analytical methods, and quality standards. In addition, the limited number of clinical-stage downstream programs results in low GMP capacity utilization, exposing suppliers to high capital requirements, uneven order flow, and project cancellation risks.
This report studies the global Circular RNA Synthesis Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circular RNA Synthesis Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circular RNA Synthesis Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circular RNA Synthesis Service total market, 2021-2032, (USD Million)
Global Circular RNA Synthesis Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Circular RNA Synthesis Service total market, key domestic companies, and share, (USD Million)
Global Circular RNA Synthesis Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Circular RNA Synthesis Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Circular RNA Synthesis Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Circular RNA Synthesis Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript Biotech Corporation, VectorBuilder, Guangzhou Geneseed Biotech, uBriGene Biosciences, Yaohai Bio-Pharma, Creative Biogene, Creative Biolabs, BOC Sciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Circular RNA Synthesis Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Circular RNA Synthesis Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Custom Synthesis
- Process Development
- Analytical and QC Services
- Other
- PIE Circularization
- Enzymatic Ligation
- Other
- Naked circRNA
- circRNA-LNP
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- GenScript Biotech Corporation
- VectorBuilder
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- Creative Biolabs
- BOC Sciences
1. How big is the global Circular RNA Synthesis Service market?
2. What is the demand of the global Circular RNA Synthesis Service market?
3. What is the year over year growth of the global Circular RNA Synthesis Service market?
4. What is the total value of the global Circular RNA Synthesis Service market?
5. Who are the Major Players in the global Circular RNA Synthesis Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Circular RNA Synthesis Service Introduction
1.2 World Circular RNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Circular RNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World Circular RNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circular RNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Circular RNA Synthesis Service Consumption Value (2021-2032)
2.2 World Circular RNA Synthesis Service Consumption Value by Region
2.2.1 World Circular RNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World Circular RNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Circular RNA Synthesis Service Consumption Value (2021-2032)
2.4 China Circular RNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe Circular RNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan Circular RNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea Circular RNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN Circular RNA Synthesis Service Consumption Value (2021-2032)
2.9 India Circular RNA Synthesis Service Consumption Value (2021-2032)
3 WORLD CIRCULAR RNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circular RNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circular RNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Circular RNA Synthesis Service in 2025
3.3 Circular RNA Synthesis Service Company Evaluation Quadrant
3.4 Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 Circular RNA Synthesis Service Market: Region Footprint
3.4.2 Circular RNA Synthesis Service Market: Company Product Type Footprint
3.4.3 Circular RNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circular RNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circular RNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Circular RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Circular RNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: Circular RNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Circular RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Circular RNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Circular RNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circular RNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies Circular RNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Circular RNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circular RNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based Circular RNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Circular RNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Circular RNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Custom Synthesis
5.2.2 Process Development
5.2.3 Analytical and QC Services
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World Circular RNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World Circular RNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CIRCULARIZATION METHOD
6.1 World Circular RNA Synthesis Service Market Size Overview by Circularization Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Circularization Method
6.2.1 PIE Circularization
6.2.2 Enzymatic Ligation
6.2.3 Other
6.3 Market Segment by Circularization Method
6.3.1 World Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026)
6.3.2 World Circular RNA Synthesis Service Market Size by Circularization Method (2027-2032)
6.3.3 World Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORMAT
7.1 World Circular RNA Synthesis Service Market Size Overview by Product Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Format
7.2.1 Naked circRNA
7.2.2 circRNA-LNP
7.2.3 Other
7.3 Market Segment by Product Format
7.3.1 World Circular RNA Synthesis Service Market Size by Product Format (2021-2026)
7.3.2 World Circular RNA Synthesis Service Market Size by Product Format (2027-2032)
7.3.3 World Circular RNA Synthesis Service Market Size Market Share by Product Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Circular RNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 CRO and CDMO Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World Circular RNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World Circular RNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GenScript Biotech Corporation
9.1.1 GenScript Biotech Corporation Details
9.1.2 GenScript Biotech Corporation Major Business
9.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Product and Services
9.1.4 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GenScript Biotech Corporation Recent Developments/Updates
9.1.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
9.2 VectorBuilder
9.2.1 VectorBuilder Details
9.2.2 VectorBuilder Major Business
9.2.3 VectorBuilder Circular RNA Synthesis Service Product and Services
9.2.4 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 VectorBuilder Recent Developments/Updates
9.2.6 VectorBuilder Competitive Strengths & Weaknesses
9.3 Guangzhou Geneseed Biotech
9.3.1 Guangzhou Geneseed Biotech Details
9.3.2 Guangzhou Geneseed Biotech Major Business
9.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Services
9.3.4 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Guangzhou Geneseed Biotech Recent Developments/Updates
9.3.6 Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
9.4 uBriGene Biosciences
9.4.1 uBriGene Biosciences Details
9.4.2 uBriGene Biosciences Major Business
9.4.3 uBriGene Biosciences Circular RNA Synthesis Service Product and Services
9.4.4 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 uBriGene Biosciences Recent Developments/Updates
9.4.6 uBriGene Biosciences Competitive Strengths & Weaknesses
9.5 Yaohai Bio-Pharma
9.5.1 Yaohai Bio-Pharma Details
9.5.2 Yaohai Bio-Pharma Major Business
9.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Services
9.5.4 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yaohai Bio-Pharma Recent Developments/Updates
9.5.6 Yaohai Bio-Pharma Competitive Strengths & Weaknesses
9.6 Creative Biogene
9.6.1 Creative Biogene Details
9.6.2 Creative Biogene Major Business
9.6.3 Creative Biogene Circular RNA Synthesis Service Product and Services
9.6.4 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Creative Biogene Recent Developments/Updates
9.6.6 Creative Biogene Competitive Strengths & Weaknesses
9.7 Creative Biolabs
9.7.1 Creative Biolabs Details
9.7.2 Creative Biolabs Major Business
9.7.3 Creative Biolabs Circular RNA Synthesis Service Product and Services
9.7.4 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Creative Biolabs Recent Developments/Updates
9.7.6 Creative Biolabs Competitive Strengths & Weaknesses
9.8 BOC Sciences
9.8.1 BOC Sciences Details
9.8.2 BOC Sciences Major Business
9.8.3 BOC Sciences Circular RNA Synthesis Service Product and Services
9.8.4 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BOC Sciences Recent Developments/Updates
9.8.6 BOC Sciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Circular RNA Synthesis Service Industry Chain
10.2 Circular RNA Synthesis Service Upstream Analysis
10.3 Circular RNA Synthesis Service Midstream Analysis
10.4 Circular RNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Circular RNA Synthesis Service Introduction
1.2 World Circular RNA Synthesis Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Circular RNA Synthesis Service Total Market by Region (by Headquarter Location)
1.3.1 World Circular RNA Synthesis Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.3 China Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.4 Europe Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.5 Japan Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.6 South Korea Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.3.8 India Based Company Circular RNA Synthesis Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circular RNA Synthesis Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Circular RNA Synthesis Service Consumption Value (2021-2032)
2.2 World Circular RNA Synthesis Service Consumption Value by Region
2.2.1 World Circular RNA Synthesis Service Consumption Value by Region (2021-2026)
2.2.2 World Circular RNA Synthesis Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Circular RNA Synthesis Service Consumption Value (2021-2032)
2.4 China Circular RNA Synthesis Service Consumption Value (2021-2032)
2.5 Europe Circular RNA Synthesis Service Consumption Value (2021-2032)
2.6 Japan Circular RNA Synthesis Service Consumption Value (2021-2032)
2.7 South Korea Circular RNA Synthesis Service Consumption Value (2021-2032)
2.8 ASEAN Circular RNA Synthesis Service Consumption Value (2021-2032)
2.9 India Circular RNA Synthesis Service Consumption Value (2021-2032)
3 WORLD CIRCULAR RNA SYNTHESIS SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circular RNA Synthesis Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circular RNA Synthesis Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Circular RNA Synthesis Service in 2025
3.3 Circular RNA Synthesis Service Company Evaluation Quadrant
3.4 Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.4.1 Circular RNA Synthesis Service Market: Region Footprint
3.4.2 Circular RNA Synthesis Service Market: Company Product Type Footprint
3.4.3 Circular RNA Synthesis Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circular RNA Synthesis Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circular RNA Synthesis Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Circular RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Circular RNA Synthesis Service Consumption Value Comparison
4.2.1 United States VS China: Circular RNA Synthesis Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Circular RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Circular RNA Synthesis Service Companies and Market Share, 2021-2026
4.3.1 United States Based Circular RNA Synthesis Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circular RNA Synthesis Service Revenue, (2021-2026)
4.4 China Based Companies Circular RNA Synthesis Service Revenue and Market Share, 2021-2026
4.4.1 China Based Circular RNA Synthesis Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circular RNA Synthesis Service Revenue, (2021-2026)
4.5 Rest of World Based Circular RNA Synthesis Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Circular RNA Synthesis Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Circular RNA Synthesis Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Custom Synthesis
5.2.2 Process Development
5.2.3 Analytical and QC Services
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3.2 World Circular RNA Synthesis Service Market Size by Type (2027-2032)
5.3.3 World Circular RNA Synthesis Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CIRCULARIZATION METHOD
6.1 World Circular RNA Synthesis Service Market Size Overview by Circularization Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Circularization Method
6.2.1 PIE Circularization
6.2.2 Enzymatic Ligation
6.2.3 Other
6.3 Market Segment by Circularization Method
6.3.1 World Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026)
6.3.2 World Circular RNA Synthesis Service Market Size by Circularization Method (2027-2032)
6.3.3 World Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORMAT
7.1 World Circular RNA Synthesis Service Market Size Overview by Product Format: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Format
7.2.1 Naked circRNA
7.2.2 circRNA-LNP
7.2.3 Other
7.3 Market Segment by Product Format
7.3.1 World Circular RNA Synthesis Service Market Size by Product Format (2021-2026)
7.3.2 World Circular RNA Synthesis Service Market Size by Product Format (2027-2032)
7.3.3 World Circular RNA Synthesis Service Market Size Market Share by Product Format (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Circular RNA Synthesis Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 CRO and CDMO Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.3.2 World Circular RNA Synthesis Service Market Size by Application (2027-2032)
8.3.3 World Circular RNA Synthesis Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GenScript Biotech Corporation
9.1.1 GenScript Biotech Corporation Details
9.1.2 GenScript Biotech Corporation Major Business
9.1.3 GenScript Biotech Corporation Circular RNA Synthesis Service Product and Services
9.1.4 GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GenScript Biotech Corporation Recent Developments/Updates
9.1.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
9.2 VectorBuilder
9.2.1 VectorBuilder Details
9.2.2 VectorBuilder Major Business
9.2.3 VectorBuilder Circular RNA Synthesis Service Product and Services
9.2.4 VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 VectorBuilder Recent Developments/Updates
9.2.6 VectorBuilder Competitive Strengths & Weaknesses
9.3 Guangzhou Geneseed Biotech
9.3.1 Guangzhou Geneseed Biotech Details
9.3.2 Guangzhou Geneseed Biotech Major Business
9.3.3 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Services
9.3.4 Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Guangzhou Geneseed Biotech Recent Developments/Updates
9.3.6 Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
9.4 uBriGene Biosciences
9.4.1 uBriGene Biosciences Details
9.4.2 uBriGene Biosciences Major Business
9.4.3 uBriGene Biosciences Circular RNA Synthesis Service Product and Services
9.4.4 uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 uBriGene Biosciences Recent Developments/Updates
9.4.6 uBriGene Biosciences Competitive Strengths & Weaknesses
9.5 Yaohai Bio-Pharma
9.5.1 Yaohai Bio-Pharma Details
9.5.2 Yaohai Bio-Pharma Major Business
9.5.3 Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Services
9.5.4 Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Yaohai Bio-Pharma Recent Developments/Updates
9.5.6 Yaohai Bio-Pharma Competitive Strengths & Weaknesses
9.6 Creative Biogene
9.6.1 Creative Biogene Details
9.6.2 Creative Biogene Major Business
9.6.3 Creative Biogene Circular RNA Synthesis Service Product and Services
9.6.4 Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Creative Biogene Recent Developments/Updates
9.6.6 Creative Biogene Competitive Strengths & Weaknesses
9.7 Creative Biolabs
9.7.1 Creative Biolabs Details
9.7.2 Creative Biolabs Major Business
9.7.3 Creative Biolabs Circular RNA Synthesis Service Product and Services
9.7.4 Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Creative Biolabs Recent Developments/Updates
9.7.6 Creative Biolabs Competitive Strengths & Weaknesses
9.8 BOC Sciences
9.8.1 BOC Sciences Details
9.8.2 BOC Sciences Major Business
9.8.3 BOC Sciences Circular RNA Synthesis Service Product and Services
9.8.4 BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BOC Sciences Recent Developments/Updates
9.8.6 BOC Sciences Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Circular RNA Synthesis Service Industry Chain
10.2 Circular RNA Synthesis Service Upstream Analysis
10.3 Circular RNA Synthesis Service Midstream Analysis
10.4 Circular RNA Synthesis Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Circular RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Circular RNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Circular RNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Circular RNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Circular RNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circular RNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Circular RNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Circular RNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Circular RNA Synthesis Service Players in 2025
Table 12. World Circular RNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Circular RNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key Circular RNA Synthesis Service Players
Table 15. Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 16. Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 17. Circular RNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China Circular RNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Circular RNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Circular RNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circular RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circular RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Circular RNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World Circular RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Circular RNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Circular RNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Circular RNA Synthesis Service Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Circular RNA Synthesis Service Market Size Value by Circularization Method (2021-2026) & (USD Million)
Table 34. World Circular RNA Synthesis Service Market Size by Circularization Method (2027-2032) & (USD Million)
Table 35. World Circular RNA Synthesis Service Market Size by Product Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Circular RNA Synthesis Service Market Size Value by Product Format (2021-2026) & (USD Million)
Table 37. World Circular RNA Synthesis Service Market Size by Product Format (2027-2032) & (USD Million)
Table 38. World Circular RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Circular RNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Circular RNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 42. GenScript Biotech Corporation Major Business
Table 43. GenScript Biotech Corporation Circular RNA Synthesis Service Product and Services
Table 44. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GenScript Biotech Corporation Recent Developments/Updates
Table 46. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 47. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 48. VectorBuilder Major Business
Table 49. VectorBuilder Circular RNA Synthesis Service Product and Services
Table 50. VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. VectorBuilder Recent Developments/Updates
Table 52. VectorBuilder Competitive Strengths & Weaknesses
Table 53. Guangzhou Geneseed Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Guangzhou Geneseed Biotech Major Business
Table 55. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Services
Table 56. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Guangzhou Geneseed Biotech Recent Developments/Updates
Table 58. Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
Table 59. uBriGene Biosciences Basic Information, Manufacturing Base and Competitors
Table 60. uBriGene Biosciences Major Business
Table 61. uBriGene Biosciences Circular RNA Synthesis Service Product and Services
Table 62. uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. uBriGene Biosciences Recent Developments/Updates
Table 64. uBriGene Biosciences Competitive Strengths & Weaknesses
Table 65. Yaohai Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 66. Yaohai Bio-Pharma Major Business
Table 67. Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Services
Table 68. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yaohai Bio-Pharma Recent Developments/Updates
Table 70. Yaohai Bio-Pharma Competitive Strengths & Weaknesses
Table 71. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 72. Creative Biogene Major Business
Table 73. Creative Biogene Circular RNA Synthesis Service Product and Services
Table 74. Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Creative Biogene Recent Developments/Updates
Table 76. Creative Biogene Competitive Strengths & Weaknesses
Table 77. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 78. Creative Biolabs Major Business
Table 79. Creative Biolabs Circular RNA Synthesis Service Product and Services
Table 80. Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Creative Biolabs Recent Developments/Updates
Table 82. Creative Biolabs Competitive Strengths & Weaknesses
Table 83. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 84. BOC Sciences Major Business
Table 85. BOC Sciences Circular RNA Synthesis Service Product and Services
Table 86. BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BOC Sciences Recent Developments/Updates
Table 88. BOC Sciences Competitive Strengths & Weaknesses
Table 89. Global Key Players of Circular RNA Synthesis Service Upstream (Raw Materials)
Table 90. Global Circular RNA Synthesis Service Typical Customers
Table 1. World Circular RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Circular RNA Synthesis Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Circular RNA Synthesis Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Circular RNA Synthesis Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Circular RNA Synthesis Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circular RNA Synthesis Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Circular RNA Synthesis Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Circular RNA Synthesis Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Circular RNA Synthesis Service Players in 2025
Table 12. World Circular RNA Synthesis Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Circular RNA Synthesis Service Company Evaluation Quadrant
Table 14. Head Office of Key Circular RNA Synthesis Service Players
Table 15. Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 16. Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 17. Circular RNA Synthesis Service Mergers & Acquisitions Activity
Table 18. United States VS China Circular RNA Synthesis Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Circular RNA Synthesis Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Circular RNA Synthesis Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circular RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 23. China Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circular RNA Synthesis Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Circular RNA Synthesis Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Circular RNA Synthesis Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Circular RNA Synthesis Service Revenue Market Share (2021-2026)
Table 29. World Circular RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Circular RNA Synthesis Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Circular RNA Synthesis Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Circular RNA Synthesis Service Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Circular RNA Synthesis Service Market Size Value by Circularization Method (2021-2026) & (USD Million)
Table 34. World Circular RNA Synthesis Service Market Size by Circularization Method (2027-2032) & (USD Million)
Table 35. World Circular RNA Synthesis Service Market Size by Product Format, (USD Million), 2021 & 2025 & 2032
Table 36. World Circular RNA Synthesis Service Market Size Value by Product Format (2021-2026) & (USD Million)
Table 37. World Circular RNA Synthesis Service Market Size by Product Format (2027-2032) & (USD Million)
Table 38. World Circular RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Circular RNA Synthesis Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Circular RNA Synthesis Service Market Size by Application (2027-2032) & (USD Million)
Table 41. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 42. GenScript Biotech Corporation Major Business
Table 43. GenScript Biotech Corporation Circular RNA Synthesis Service Product and Services
Table 44. GenScript Biotech Corporation Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GenScript Biotech Corporation Recent Developments/Updates
Table 46. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 47. VectorBuilder Basic Information, Manufacturing Base and Competitors
Table 48. VectorBuilder Major Business
Table 49. VectorBuilder Circular RNA Synthesis Service Product and Services
Table 50. VectorBuilder Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. VectorBuilder Recent Developments/Updates
Table 52. VectorBuilder Competitive Strengths & Weaknesses
Table 53. Guangzhou Geneseed Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Guangzhou Geneseed Biotech Major Business
Table 55. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Product and Services
Table 56. Guangzhou Geneseed Biotech Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Guangzhou Geneseed Biotech Recent Developments/Updates
Table 58. Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
Table 59. uBriGene Biosciences Basic Information, Manufacturing Base and Competitors
Table 60. uBriGene Biosciences Major Business
Table 61. uBriGene Biosciences Circular RNA Synthesis Service Product and Services
Table 62. uBriGene Biosciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. uBriGene Biosciences Recent Developments/Updates
Table 64. uBriGene Biosciences Competitive Strengths & Weaknesses
Table 65. Yaohai Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 66. Yaohai Bio-Pharma Major Business
Table 67. Yaohai Bio-Pharma Circular RNA Synthesis Service Product and Services
Table 68. Yaohai Bio-Pharma Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Yaohai Bio-Pharma Recent Developments/Updates
Table 70. Yaohai Bio-Pharma Competitive Strengths & Weaknesses
Table 71. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 72. Creative Biogene Major Business
Table 73. Creative Biogene Circular RNA Synthesis Service Product and Services
Table 74. Creative Biogene Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Creative Biogene Recent Developments/Updates
Table 76. Creative Biogene Competitive Strengths & Weaknesses
Table 77. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 78. Creative Biolabs Major Business
Table 79. Creative Biolabs Circular RNA Synthesis Service Product and Services
Table 80. Creative Biolabs Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Creative Biolabs Recent Developments/Updates
Table 82. Creative Biolabs Competitive Strengths & Weaknesses
Table 83. BOC Sciences Basic Information, Manufacturing Base and Competitors
Table 84. BOC Sciences Major Business
Table 85. BOC Sciences Circular RNA Synthesis Service Product and Services
Table 86. BOC Sciences Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BOC Sciences Recent Developments/Updates
Table 88. BOC Sciences Competitive Strengths & Weaknesses
Table 89. Global Key Players of Circular RNA Synthesis Service Upstream (Raw Materials)
Table 90. Global Circular RNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. Circular RNA Synthesis Service Picture
Figure 2. World Circular RNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Circular RNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Circular RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Circular RNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. Circular RNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Circular RNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circular RNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circular RNA Synthesis Service Markets in 2025
Figure 27. United States VS China: Circular RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Circular RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Circular RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Custom Synthesis
Figure 32. Process Development
Figure 33. Analytical and QC Services
Figure 34. Other
Figure 35. World Circular RNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World Circular RNA Synthesis Service Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 37. World Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 38. PIE Circularization
Figure 39. Enzymatic Ligation
Figure 40. Other
Figure 41. World Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2032)
Figure 42. World Circular RNA Synthesis Service Market Size by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 44. Naked circRNA
Figure 45. circRNA-LNP
Figure 46. Other
Figure 47. World Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2032)
Figure 48. World Circular RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. CRO and CDMO Companies
Figure 52. Other
Figure 53. World Circular RNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. Circular RNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Circular RNA Synthesis Service Picture
Figure 2. World Circular RNA Synthesis Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Circular RNA Synthesis Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Circular RNA Synthesis Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Circular RNA Synthesis Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Circular RNA Synthesis Service Revenue (2021-2032) & (USD Million)
Figure 13. Circular RNA Synthesis Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Circular RNA Synthesis Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circular RNA Synthesis Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circular RNA Synthesis Service Markets in 2025
Figure 27. United States VS China: Circular RNA Synthesis Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Circular RNA Synthesis Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Circular RNA Synthesis Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 31. Custom Synthesis
Figure 32. Process Development
Figure 33. Analytical and QC Services
Figure 34. Other
Figure 35. World Circular RNA Synthesis Service Market Size Market Share by Type (2021-2032)
Figure 36. World Circular RNA Synthesis Service Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 37. World Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 38. PIE Circularization
Figure 39. Enzymatic Ligation
Figure 40. Other
Figure 41. World Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2032)
Figure 42. World Circular RNA Synthesis Service Market Size by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 43. World Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 44. Naked circRNA
Figure 45. circRNA-LNP
Figure 46. Other
Figure 47. World Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2032)
Figure 48. World Circular RNA Synthesis Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 50. Pharmaceutical and Biotechnology Companies
Figure 51. CRO and CDMO Companies
Figure 52. Other
Figure 53. World Circular RNA Synthesis Service Market Size Market Share by Application (2021-2032)
Figure 54. Circular RNA Synthesis Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
